Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,104 public trials 3,998 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

CD45BE-HSPC + CART-45 Cells

NCT07451054

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome

NCT04608110

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Nippon Medical School Hospital Bunkyō City, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Saitama Medical University Hospital Iruma, Japan
  • University Hospital, Kyoto Prefectural University of Medicine Kyoto, Japan
View Trial Details
Recruiting

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

NCT05308264

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 15 locations
View Trial Details
Recruiting

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

NCT05611801

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Arbesu Hematología Mendoza, Argentina
  • Murdoch Children's Research Institute Parkville, Australia
  • Medizinische Universität Wien Vienna, State of Vienna, Austria
  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View all 64 locations
View Trial Details
Recruiting

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

NCT06092892

Conditions
Axilla; Breast, Axillary Nodal Disease, Breast Cancer, +12 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • CS Cancer at Huntington Cancer Center Pasadena, California, United States
  • CS Cancer at Valley Oncology Medical Group Tarzana, California, United States
View Trial Details
Recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

NCT06287229

Conditions
B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NCT06697184

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details

Related conditions